122 related articles for article (PubMed ID: 15786011)
1. Frequency of loss of heterozygosity at 3 p, 9 p, 13 q, and 17 p is related to proliferative activity in smokers with stage I non-small cell lung cancer.
Haga Y; Hiroshima K; Iyoda A; Kohno H; Shibuya K; Iizasa T; Fujisawa T; Ohwada H
Thorac Cardiovasc Surg; 2005 Apr; 53(2):114-7. PubMed ID: 15786011
[TBL] [Abstract][Full Text] [Related]
2. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
Tseng JE; Kemp BL; Khuri FR; Kurie JM; Lee JS; Zhou X; Liu D; Hong WK; Mao L
Cancer Res; 1999 Oct; 59(19):4798-803. PubMed ID: 10519387
[TBL] [Abstract][Full Text] [Related]
3. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
6. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
[TBL] [Abstract][Full Text] [Related]
7. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
[TBL] [Abstract][Full Text] [Related]
10. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
[TBL] [Abstract][Full Text] [Related]
12. [Studies of microsatellite instability and loss of heterozygosity at chromosome 17 in non-small cell lung carcinoma].
Guo X; Ni P; Li L
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Dec; 22(12):743-5. PubMed ID: 11776784
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
[TBL] [Abstract][Full Text] [Related]
15. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
[TBL] [Abstract][Full Text] [Related]
16. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
18. [Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung].
Sánchez Céspedes M; López Cabrerizo MP; Moreno I; Ariza A; Monzó M; Rosell R
Med Clin (Barc); 1997 May; 109(1):1-5. PubMed ID: 9303970
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite alterations in non-small cell lung cancer.
Petmitr S; Nuchfaong S; Chaksangchaichot P; Pongstaporn W; Sutinont P; Limsila T; Punyarit P
J Exp Clin Cancer Res; 2002 Mar; 21(1):31-5. PubMed ID: 12071526
[TBL] [Abstract][Full Text] [Related]
20. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
